Dr. Burris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 25th Ave N
Ste 100
Nashville, TN 37203Phone+1 615-320-5090
Education & Training
- San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1991
- San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1985 - 1988
- University of South Alabama College of MedicineClass of 1985
Certifications & Licensure
- TN State Medical License 1997 - 2025
- TX State Medical License 1991 - 2025
- PA State Medical License 1988 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2010
Clinical Trials
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer Start of enrollment: 2001 Apr 01
- Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer Start of enrollment: 2000 Nov 01
- Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors Start of enrollment: 2002 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 236 citationsOverall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, Yoon-Sim Yap, Gabe S Sonke
The New England Journal of Medicine. 2022-03-10 - 4551 citationsImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.H. A. Burris, Malcolm J. Moore, J. S. Andersen, M R Green, Mace L. Rothenberg
Journal of Clinical Oncology. 1997-06-01 - 298 citationsDurvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka
NEJM Evidence. 2022-08-01
Lectures
- Maintenance of health-related quality of life in elderly patients treated with ribociclib + letrozole in MONALEESA-2.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Most Patients Should Be Tested2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
- 7th Community Oncology ConferenceGlobal Academy for Medical Education (Elsevier), Las Vegas, Nevada - 3/30/2012
Press Mentions
- Hydroxychloroquine Combination Risky for Cancer Patients with COVID-19May 29th, 2020
- New Drugs Make Headway Against Lung, Prostate, Colon CancersMay 29th, 2020
- Patients with Certain Cancers Are Nearly Three Times as Likely to Die of Covid-19, Study SaysApril 28th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: